OliX presents preclinical data on anti-NASH siRNA and Semaglutide combination treatment for weight loss

During the conference’s poster session, OliX revealed preclinical study results of OLX702A, addressing key mechanisms involved in NASH and obesity. T...

May 15, 2023 | Monday | News
Nona Biosciences partners with PharmaEssentia Innovation Research Center.

"We are pleased to enter this strategic collaboration with PharmaEssentia," Jingsong Wang, M.D., PhD, Chairman of Nona Biosciences, said, " PharmaEssentia'...

May 12, 2023 | Friday | News
Veeva Partners with Sanofi to Transform its Quality System

Veeva Systems (NYSE: VEEV) today announced that Sanofi is implementing Veeva Vault QMS and Veeva Vault QualityDocs to modernize quality management across t...

May 11, 2023 | Thursday | News
UCB and Ariceum Therapeutics Partner for Immune-Related Disease and Cancer Treatment Research

UCB's expertise in macrocyclic peptide discovery, using its proprietary mRNA-display platform, ExtremeDiversity™, will aid Ariceum's discovery of t...

May 11, 2023 | Thursday | News
PharmAbcine to participate in "BIO International Convention 2023"

Details of the events are as follows: Event: Event: BIO International ConventionDate: June 5-8, 2023Registration: https://www.bio.org/events/bio-internati...

May 09, 2023 | Tuesday | News
Junshi Biosciences and Dr. Reddy's Partner to Develop Toripalimab in 21 Countries.

“We are thrilled to have established a partnership with Dr. Reddy’s while toripalimab’s global commercial network has been steadily expan...

May 08, 2023 | Monday | News
SomaLogic Launches Proteomics Grant Program for APAC Researchers

SomaLogic, Inc., a global leader in proteomics technology, announced that it is sponsoring the Genomax Research Grant Award for researchers in Singapore. T...

May 08, 2023 | Monday | News
Akorn Recalls Expired Human and Animal Drugs Nationwide Due to Shutdown

Akorn Operating Company LLC has filed Chapter 7 bankruptcy on February 23, 2023. In connection with that filing, the company has ceased and shutdow...

May 04, 2023 | Thursday | Regulatory
EirGenix's EG1206A Meets Phase 1 Trial Objectives as Breast Cancer Biosimilar

EG1206A is a biosimilar drug of the second-generation HER2-positive antibody drug Perjeta® (pertuzumab). EG1206A has a unique binding mechanism for HER...

May 03, 2023 | Wednesday | News
Merck to Establish BioProcessing Production Center in South Korea

MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daejeon City...

May 03, 2023 | Wednesday | News
Study Suggests Catalyst for Human Brain Evolution

More than a million years ago, large chunks of the human genome were rearranged—a chance event during egg or sperm formation that led to the deletion...

May 01, 2023 | Monday | News
Pfizer and Astellas' XTANDI® Combo Proves Effective in Reducing Prostate Cancer Metastasis Risk by 58%: Phase 3 EMBARK Trial Results Revealed

Data from Phase 3 EMBARK trial to be presented as a plenary session during the 2023 American Urological Association Annual Meeting Res...

May 01, 2023 | Monday | News
Janssen Reports First Results of TAR-200 and Cetrelimab Study in Non-Muscle-Invasive Bladder Cancer

Study results of novel drug-eluting technology highlight potential durability of TAR-200 in patient population with high unmet need T...

May 01, 2023 | Monday | News
Brenus Pharma Unveils Preclinical Results for Promising New Cancer Drug STC-10101

Brenus Pharma Announces two groundbreaking presentations on STC-1010, the company's first drug candidate for colorectal cancer (CRC), produced by Brenus Ph...

April 28, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close